Chapter 151: The number of volunteers has increased dramatically
When Zhang Chen and the others were eating, Zhang Yue's mobile phone kept ringing.
In the clinical trial of the "Lanyue 001" project, Zhang Yue has always been responsible for recruiting subjects, and the information left to the outside world is also hers.
What Zhang Yue said when she answered the phone, everyone listened to it.
During the whole meal, he answered no less than 30 phone calls in total.
So much so, plus the volunteers who were arranged in Shaocheng People's Hospital before.
Now the number of subjects in the second phase of the clinical trial is full in an instant.
Even after the full capacity, there were quite a few calls coming in.
Zhang Chen had to arrange them in the third phase of the clinical trial.
At the same time, after discussion, it was unanimously decided.
By the time of the second phase of the clinical trial, the condolence fee was reduced to 200,000 yuan, and the condolence fee of the third phase clinical trial was reduced to 50,000 yuan.
What Zhang Chen meant before was that whether it was the second or third phase, he would give 500,000 condolences to him.
But later, after Tian Wenbin's reminder, Zhang Chen decided to reduce the standard of condolence fees for the second and third phases.
In the phase I clinical trial, the company's Lanyue 001 gene drug is a complete new drug for everyone.
For the subjects, they took a lot of risks to participate in the test segment.
So this money, Zhang Chen is willing to give, because trust is priceless.
However, as long as the results of the Phase 1 clinical trial of Lanyue 001 are disseminated, everyone will have less concerns.
For them, the risk is reduced.
Therefore, in Zhang Chen's view, it makes sense to reduce the condolence fee in the subsequent clinical trials.
You can save that money and use it where it's needed more.
"It is estimated that there are patients who have been discharged from the hospital, and it has begun to spread to the outside world, and the speed of transmission is very fast."
Tian Wenbin was amazed, when he recruited subjects before, the speed was really not so fast.
But now, just after a meal, there have been more than 30 phone calls.
"I have personal experience of this, I know that a Chinese medicine doctor sees a doctor well, and as a result, many people in the neighborhood rush to see him, and finally every time this doctor goes out of the clinic, he has to see 90 o'clock in the evening."
Zhao Yingbo said with a smile.
"This is a good thing, the volunteers of the second phase of the clinical trial do not have to worry in the future, it is estimated that if you wait a little longer, the subjects of the third phase can be directly recruited." Zhang Chen said with a smile.
Zhang Yue's eyes twitched, and she said, "Since all the subjects here in Shaocheng have been arranged, then you can arrange them all to other hospitals." ”
"This is okay, but I don't know what the situation is in the capital, I don't think there should be a shortage of clinical subjects there, but there may be a shortage of volunteers in West China Hospital, Sichuan Prefecture, and the number of volunteers may be insufficient, let's see how it will be when the time comes."
Zhang Chen nodded, thinking that this method could be used.
At present, Shaocheng People's Hospital is the first to complete the phase I clinical trial.
And those patients who have received treatment will definitely share this magical experience with their relatives and friends.
But no matter how much you share, it is estimated that it will not reach Sichuan Mansion, which is too far away from Shaocheng.
In order to celebrate the successful conclusion of the first phase of the clinical trial of Shaocheng People's Hospital, everyone was very happy and drank a little wine.
After eating, Zhang Chen called the company's driver and sent everyone to their respective homes.
Now that the company's vehicles have been transformed and strengthened by Canaanite bacillus, Zhang Chen is not worried about everyone's safety.
After the strengthened car, let alone blocking bullets, even an RPG individual missile is estimated to be unable to hit.
After returning home, Jiang Shumin made Zhang Chen tea.
Zhang Chen didn't feel any better after drinking.
He shook his head, feeling that the current hangover products were all gimmicky products that were useless.
I thought that I should develop hangover products in advance.
It is estimated that many people have this demand, and the market size is very large.
Especially for a country like Huaguo, which has a rich wine table culture.
Zhang Chen got up and went to the bathroom to wash his face a few times, and after getting a little better, he returned to the study and continued to read the system information.
He took an intermediate-grade [Quick Thinking Capsule].
What he didn't expect was that after taking the study capsule, the whole person instantly sobered up, and there was no feeling of dizziness after drinking.
This gave Zhang Chen a big surprise, could it be that learning capsules still has the effect of hangover?
He took several capsules in a row until 12 o'clock at night before going to bed.
......
Sujiang Mansion, Sioux City.
Sioux City has grown very fast in recent years.
Especially with the completion of various industrial parks, coupled with various government support policies.
As a result, many large and medium-sized enterprises have successively established branches in Sioux City, and even many small companies have set up their headquarters directly in Sioux City.
Sioux City Bio-Industrial Park has just been established and is an innovation base for the development of the industrial park's biological industry.
More than 500 high-tech R&D enterprises of all sizes have gathered in the park, forming industrial clusters such as new drug creation, medical devices, and biotechnology.
Xingrui Gene Technology Co., Ltd. is an emerging company founded in 2018.
Their company is mainly engaged in the research and development of gene therapy drugs, without any means of generating revenue, and has survived until now by financing alone.
To make such a decision, their founders also made a lot of determination.
In fact, in terms of their scientific research level, they can completely accept some external scientific research services.
Although the scientific research services received in this way can only be regarded as a drop in the bucket for the entire company's R&D expenses.
But if you have some income, it is also a good thing for the company to relieve some economic pressure.
But Zhao Chunlin devoted himself to research and development, and did not care about scientific research services at all.
But recently, Zhao Chunlin has encountered a big problem.
The company has more than 10 doctors, large and small, but they have not been able to think of a specific solution.
Seeing that the company's gene therapy drugs for the treatment of ophthalmic diseases can be applied for clinical trials immediately.
But it may be that God is jealous of talents, and when I recently went to the monkey test, there was a sudden accident.
After administration, one of the monkeys developed severe inflammation of the eyeball, and one of the control monkeys died outright.
This caused the whole company to fall into a state of panic.
Everyone can't think of the reason for this phenomenon.
In the end, everyone unanimously decided to switch to humanized experimental animals, maybe there will be good results.
However, this disease is a rare disease, and its disease model is very difficult to establish.
The project manager in charge of this project searched all over the country for companies and institutions that make laboratory animals.
But there is still no one who can give him a definite answer.
At the same time, Zhao Chunlin also exhausted all kinds of contacts around him.
But I also didn't find a suitable company or institution.
For this reason, he was so worried that he couldn't sleep well every day.
Seeing that there are many more gray hairs, his weight has dropped from 160 pounds to 120 pounds.
He was the first class of biology graduates of Tsinghua University, and even Shi Yigong, vice president of Tsinghua University, was her classmate.
After returning from abroad, the network has expanded a lot.
But even with such a good connection, Zhao Chunlin still didn't find the right company.
Today he didn't even eat lunch and kept sitting in his office smoking.
If this continues, it is estimated that it will be difficult to raise funds next time.
Then the entire capital chain will be broken, and the company will definitely not be able to operate, and then it can only declare bankruptcy.
It's not easy to get to this point.
In Zhao Chunlin's opinion, there is no problem with their drug design at all, and he is very unwilling to give up.
Just then, there was a knock on the office door.
The director of the QC quality inspection department walked into the office excitedly.
He said with excitement on his face: "Zhao Bo, I have found a company that can make experimental animal models for us, you can take a look at this latest guiding principle." ”